Lakeland, FL -- (SBWIRE) -- 09/11/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stock picks. Here Penny Stock Divas brings a special report on: CANADIAN OIL SANDS(OTCMKTS:COSWF),DETOUR GOLD CORP(OTCMKTS:DRGDF),Guided Therapeutics Inc(OTCBB:GTHP), PacWest Equities Inc(OTCMKTS:PWEI)
CANADIAN OIL SANDS(OTCMKTS:COSWF) stock is at $19.52, down -0.63 percent from its previous close of $19.64. The stock opened the last trading session at $19.59 and touched its highest price point at $19.59. Its lowest price point for the session stood at $19.47.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative -0.61% during the previous three months trade.
Its total trading volume is 61570 shares for the day, in comparison to its average trading volume of 63854 shares.
Canadian Oil Sands Limited, through its indirect interest in the Syncrude Joint Venture, engages in mining, extracting, and upgrading bitumen from oil sands in northern Alberta.
What COSWF Charts Are Signaling for Traders? Find Out Here
DETOUR GOLD CORP(OTCMKTS:DRGDF) started its trading session with the price of $10.15 and closed at $10.00 by declining -7.16%.
Previous 5 days graph demonstrated an adverse move of –9.26%. DRGDF’s quarterly performance remained in the red with the percentage of -7.95, DRGDF’s stocks traded with total volume of 56731 shares, while the average trading volume remained 38673 shares.
Detour Gold Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada. The company primarily explores for gold.
Is DRGDF Buy After The Recent Price Movement? Find Out Here
Guided Therapeutics Inc(OTCBB:GTHP) percentage change mounted 0.88%, to close at $0.575 with the total traded volume of 627577 shares, less than average volume of 102445.
Company’s year to date performance remained negative with the fall of -15.44%. If we look at the last 6 months of trade, that is in the bearish zone with an fall of -15.07%
The 52-week price range of the stock remained $0.47 - $0.98, while during last trade its minimum price was $0.52 and it gained its highest price of $0.58.
Guided Therapeutics, Inc., formerly SpectRx, Inc., is a medical technology company focused on developing medical devices. Its primary focus is the development of its cervical cancer detection technology (LightTouch) and extension of its cancer detection platform into other cancers, especially lung and esophageal.
Should GTHP a Buy or Sell Now? Find Out Here
PacWest Equities Inc(OTCMKTS:PWEI) stock closed at $0.0455, up 1.11 percent from its previous close of $0.05. Its today’s volume is 3.65M shares, in comparison to its average trading volume of 1.42M shares. The stock opened the session at $0.05 and touched its highest price point at $0.06.
The lowest price point for the stock stood at $0.04 whereas its 52 week price range stands at $0.02 - $0.80. The company has a total of 1.47 billion outstanding shares and its total market capitalization is $66.82 million. Its beta value stands at -0.
PacWest Equities Inc., specializes in working with underperforming companies and bringing together the resources needed for them to attain financial stability and growth.
What PWEI Charts Are Signaling for Traders? Find Out Here
About Penny Stock Divas
PSD is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our penny stock picks. We use social media tools such as Twitter and Facebook, enabling you to receive time sensitive information in a real-time manner. When you sign up for our FREE penny stock newsletter, you will receive our latest hot penny stock alerts! We have new investment ideas for penny stocks with research and commentary in the penny stock market.
PSD is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)